These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34622351)

  • 41. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 42. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival.
    Rhu J; Kim JM; Choi GS; Kwon CHD; Joh JW
    Ann Surg Treat Res; 2018 Sep; 95(3):152-160. PubMed ID: 30182022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
    Murali AR; Patil S; Phillips KT; Voigt MD
    Transplantation; 2017 Aug; 101(8):e249-e257. PubMed ID: 28282359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short- and long-term outcomes after salvage liver transplantation versus primary liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Zhu Y; Dong J; Wang WL; Li MX; Lu Y
    Transplant Proc; 2013 Nov; 45(9):3329-42. PubMed ID: 24182812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
    Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
    Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients.
    Akbulut S; Kayaalp C; Yilmaz M; Ince V; Ozgor D; Karabulut K; Eris C; Toprak HI; Aydin C; Yilmaz S
    World J Gastroenterol; 2013 Mar; 19(10):1625-31. PubMed ID: 23538988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.
    Zhang HM; Jiang WT; Pan C; Deng YL; Zheng H; Shen ZY
    Transplant Proc; 2015 Mar; 47(2):438-44. PubMed ID: 25769587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early versus late recurrence of centrally located hepatocellular carcinoma after mesohepatectomy: A cohort study based on the STROBE guidelines.
    Zhao J; Li W; Mao J
    Medicine (Baltimore); 2019 Jun; 98(23):e15540. PubMed ID: 31169667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multivariate analysis of recurrence of hepatocellular carcinoma after liver transplantation].
    Wu C; Shan H
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2023-7. PubMed ID: 23253801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant.
    Ng KK; Lo CM; Liu CL; Poon RT; Chan SC; Fan ST
    Arch Surg; 2008 Jan; 143(1):68-74; discussion 74. PubMed ID: 18209155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
    Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
    World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Kostakis ID; Machairas N; Prodromidou A; Stamopoulos P; Garoufalia Z; Fouzas I; Sotiropoulos GC
    Transplant Proc; 2019 Mar; 51(2):433-436. PubMed ID: 30879559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
    Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
    Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.